Abstract
Background Although hypothesized to be the root cause of the pulse oximetry disparities, skin tone and its use for improving medical therapies have yet to be extensively studied. Studies previously used self-reported race as a proxy variable for skin tone. However, this approach cannot account for skin tone variability within race groups and also risks the potential to be confounded by other non-biological factors when modeling data. Therefore, to better evaluate health disparities associated with pulse oximetry, this study aimed to create a unique baseline dataset that included skin tone and electronic health record (EHR) data.
Methods Patients admitted to Duke University Hospital were eligible if they had at least one pulse oximetry value recorded within 5 minutes before an arterial blood gas (ABG) value. We collected skin tone data at 16 different body locations using multiple devices, including administered visual scales, colorimetric, spectrophotometric, and photography via mobile phone cameras. All patients’ data were linked in Duke’s Protected Analytics Computational Environment (PACE), converted into a common data model, and then de-identified before publication in PhysioNet.
Results Skin tone data were collected from 128 patients. We assessed 167 features per skin location on each patient. We also collected over 2000 images from mobile phones measured in the same controlled environment. Skin tone data are linked with patients’ EHR data, such as laboratory data, vital sign recordings, and demographic information.
Conclusions Measuring different aspects of skin tone for each of the sixteen body locations and linking them with patients’ EHR data could assist in the development of a more equitable AI model to combat disparities in healthcare associated with skin tone. A common data model format enables easy data federation with similar data from other sources, facilitating multicenter research on skin tone in healthcare.
Description A prospectively collected EHR-linked skin tone measurements database in a common data model with emphasis on pulse oximetry disparities.
Competing Interest Statement
AIW holds equity and management roles in Ataia Medical. AIW is supported by REACH Equity under the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health under U54MD012530. Dr. Gichoya is a 2022 Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program and declares support from RSNA Health Disparities grant (#EIHD2204), Lacuna Fund (#67), Gordon and Betty Moore Foundation, NIH (NIBIB) MIDRC grant under contracts 75N92020C00008 and 75N92020C00021, and NHLBI Award Number R01HL167811.
Funding Statement
Dr. Wong is supported by the Duke CTSI by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under UL1TR002553 and REACH Equity under the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health under U54MD012530. Dr. Gichoya is a 2022 Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program and declares support from RSNA Health Disparities grant (#EIHD2204), Lacuna Fund (#67), Gordon and Betty Moore Foundation, NIH (NIBIB) MIDRC grant under contracts 75N92020C00008 and 75N92020C00021, and NHLBI Award Number R01HL167811. Dr. Cox is funded by UG3 HL168487 and U01 AT009974.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Duke Health IRB under Pro00110842 on 18 May 2022, titled “ENCODE (mEasuring skiN Color to correct pulse Oximetry DisparitiEs).”
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
This dataset is currently under review on PhysioNet.
